Nucleostemin

References

• Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16:15 - 17
   Google Scholar
• Dai MS, Zeng SX, Jin Y, Sun XX, David L, Lu H. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol 2004; 24:7654 - 7668
   PubMed Web of Science ®Google Scholar
• Jin A, Itahana K, O'Keefe K, Zhang Y. Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol 2004; 24:7669 - 7680
   PubMed Web of Science ®Google Scholar
• Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004; 279:44475 - 44482
   PubMed Web of Science ®Google Scholar
• Sun XX, Dai MS, Lu H. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem 2007; 282:8052 - 8059
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Chen L, Chen J. MDMX regulation of p53 response to ribosomal stress. EMBO J 2006; 25:5614 - 5625
   PubMed Web of Science ®Google Scholar
• Pestov DG, Strezoska Z, Lau LF. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 2001; 21:4246 - 4255
   PubMed Web of Science ®Google Scholar
• Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 2003; 12:1151 - 1164
   PubMed Web of Science ®Google Scholar
• Bhat KP, Itahana K, Jin A, Zhang Y. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J 2004; 23:2402 - 2412
   PubMed Web of Science ®Google Scholar
• Sun XX, MS D, Lu H. Mycophenolic Acid Activation of p53 Requires Ribosomal Proteins L5 and L11. J Biol Chem 2008; 283:12387 - 12392
   PubMed Web of Science ®Google Scholar
• Daigle DM, Brown ED. Studies of the interaction of Escherichia coli YjeQ with the ribosome in vitro. J Bacteriol 2004; 186:1381 - 1387
   PubMed Web of Science ®Google Scholar
• Dai MS, Shi D, Jin Y, Sun XX, Zhang Y, Grossman SR, et al. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J Biol Chem 2006; 281:24304 - 24313
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang Z, Li M, Wang W, Li Y, Rayburn ER, et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein and activation of p53 function. Oncogene 2007; 26:5029 - 5037
   PubMed Web of Science ®Google Scholar
• Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, et al. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 2009; 35:316 - 326
   PubMed Web of Science ®Google Scholar
• Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387:296 - 299
   PubMed Web of Science ®Google Scholar
• Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 1997; 420:25 - 27
   PubMed Web of Science ®Google Scholar
• Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387:299 - 303
   PubMed Web of Science ®Google Scholar
• Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005; 123:49 - 63
   PubMed Web of Science ®Google Scholar
• Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB, Oren M. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell 2008; 32:180 - 189
   PubMed Web of Science ®Google Scholar
• An WG, Chuman Y, Fojo T, Blagosklonny MV. Inhibitors of transcription, proteasome inhibitors and DNA-damaging drugs differentially affect feedback of p53 degradation. Exp Cell Res 1998; 244:54 - 60
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, Demidenko ZN, Fojo T. Inhibition of transcription results in accumulation of Wt p53 followed by delayed outburst of p53-inducible proteins: p53 as a sensor of transcriptional integrity. Cell Cycle 2002; 1:67 - 74
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Blagosklonny MV. Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. Cancer Res 2004; 64:3653 - 3660
   PubMed Web of Science ®Google Scholar
• Dai MS, Sun XX, Lu H. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol 2008; 28:4365 - 4376
   PubMed Web of Science ®Google Scholar
• Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002; 16:2991 - 3003
   PubMed Web of Science ®Google Scholar
• Fan Y, Liu Z, Zhao S, Lou F, Nilsson S, Ekman P, et al. Nucleostemin mRNA is expressed in both normal and malignant renal tissues. Br J Cancer 2006; 94:1658 - 1662
   PubMed Web of Science ®Google Scholar
• Kafienah W, Mistry S, Williams C, Hollander AP. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells 2006; 24:1113 - 1120
   PubMed Web of Science ®Google Scholar
• Liu SJ, Cai ZW, Liu YJ, Dong MY, Sun LQ, Hu GF, et al. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies. World J Gastroenterol 2004; 10:1246 - 1249
   PubMed Web of Science ®Google Scholar
• Beekman C, Nichane M, De Clercq S, Maetens M, Floss T, Wurst W, et al. Evolutionarily conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development. Mol Cell Biol 2006; 26:9291 - 9301
   PubMed Web of Science ®Google Scholar
• Zhu Q, Yasumoto H, Tsai RY. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol 2006; 26:9279 - 9290
   PubMed Web of Science ®Google Scholar
• Ma H, Pederson T. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell 2007; 18:2630 - 2635
   PubMed Web of Science ®Google Scholar
• Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609 - 622
   PubMed Web of Science ®Google Scholar
• Lohrum MA, et al. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003; 3:577 - 587
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA, et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003; 23:8902 - 8912
   PubMed Web of Science ®Google Scholar
• Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999; 1:20 - 26
   PubMed Web of Science ®Google Scholar
• Tsai RY, McKay RD. A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J Cell Biol 2005; 168:179 - 184
   PubMed Web of Science ®Google Scholar
• Romanova L, Grand A, Zhang L, Rayner S, Katoku-Kikyo N, Kellner S, et al. Critical role of nucleostemin in pre-rRNA processing. J Biol Chem 2009; 284:4968 - 4977
   PubMed Web of Science ®Google Scholar
• Anand B, Verma SK, Prakash B. Structural stabilization of GTP-binding domains in circularly permuted GTPases: implications for RNA binding. Nucleic Acids Res 2006; 34:2196 - 2205
   PubMed Web of Science ®Google Scholar
• Bassler J, Kallas M, Hurt E. The NUG1 GTPase reveals and N-terminal RNA-binding domain that is essential for association with 60S pre-ribosomal particles. J Biol Chem 2006; 281:24737 - 24744
   PubMed Web of Science ®Google Scholar
• Saveanu C, Bienvenu D, Namane A, Gleizes PE, Gas N, Jacquier A, et al. Nog2p, a putative GTPase associated with pre-60S subunits and required for late 60S maturation steps. EMBO J 2001; 20:6475 - 6484
   PubMed Web of Science ®Google Scholar
• Reynaud EG, Andrade MA, Bonneau F, Ly TB, Knop M, Scheffzek K, et al. Human Lsg1 defines a family of essential GTPases that correlates with the evolution of compartmentalization. BMC Biol 2005; 3:21
   PubMed Web of Science ®Google Scholar
• Yang H, Zhou J, Ochs RL, Henning D, Jin R, Valdez BC. Downregulation of RNA helicase II/Gu results in the depletion of 18 and 28 S rRNAs in Xenopus oocyte. J Biol Chem 2003; 278:38847 - 38859
   PubMed Web of Science ®Google Scholar
• Holmstrom TH, Mialon A, Kallio M, Nymalm Y, Mannermaa L, Holm T, et al. c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21. J Biol Chem 2008; 283:7046 - 7053
   PubMed Web of Science ®Google Scholar
• Lapik YR, Fernandes CJ, Lau LF, Pestov DG. Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis. Mol Cell 2004; 15:17 - 29
   PubMed Web of Science ®Google Scholar
• Wade C, Shea KA, Jensen RV, McAlear MA. EBP2 is a member of the yeast RRB regulon, a transcriptionally coregulated set of genes that are required for ribosome and rRNA biosynthesis. Mol Cell Biol 2001; 21:8638 - 8650
   PubMed Web of Science ®Google Scholar
• Huang M, Itahana K, Zhang Y, Mitchell BS. Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin. Cancer Res 2009; 69:3004 - 3012
   PubMed Web of Science ®Google Scholar
• Legube G, Linares LK, Lemercier C, Scheffner M, Khochbin S, Trouche D. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J 2002; 21:1704 - 1712
   PubMed Web of Science ®Google Scholar
• Kinyamu HK, Archer TK. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol Cell Biol 2003; 23:5867 - 5881
   PubMed Web of Science ®Google Scholar
• Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 2001; 294:1307 - 1313
   PubMed Web of Science ®Google Scholar
• Pan Y, Chen J. MDM2 promotes ubiquitination and degradation of MDMX. Mol Cell Biol 2003; 23:5113 - 5121
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang H, et al. MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53. J Biol Chem 2004; 279:16000 - 16006
   PubMed Web of Science ®Google Scholar
• Jin Y, Lee H, Zeng SX, Dai MS, Lu H. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J 2003; 22:6365 - 6377
   PubMed Web of Science ®Google Scholar
• Rosby R, Cui Z, Rogers E, deLivron MA, Robinson VL, DiMario PJ. Knockdown of the Drosophila GTPase nucleostemin 1 impairs large ribosomal subunit biogenesis, cell growth and midgut precursor cell maintenance. Mol Biol Cell 2009; 20:4424 - 4434
   PubMed Web of Science ®Google Scholar
• Lunardi A, Di Minin G, Provero P, Dal Ferro M, Carotti M, Del Sal G, et al. A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network. Proc Natl Acad Sci USA 107:6322 - 6327
   PubMed Web of Science ®Google Scholar
• Ye F, Zhou C, Cheng Q, Shen J, Chen H. Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 2008; 8:108
   PubMed Web of Science ®Google Scholar
• Cada Z, Boucek J, Dvorankova B, Chovanec M, Plzak J, Kodets R, et al. Nucleostemin expression in squamous cell carcinoma of the head and neck. Anticancer Res 2007; 27:3279 - 3284
   PubMed Web of Science ®Google Scholar
• Tamase A, Muraguchi T, Naka K, Tanaka S, Kinoshita M, Hoshii T, et al. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci USA 2009; 106:17163 - 17168
   PubMed Web of Science ®Google Scholar